<DOC>
	<DOCNO>NCT00237783</DOCNO>
	<brief_summary>Low blood pressure ( hypotension ) dialysis afflict approximately 25 % hemodialysis patient . In pilot study , evaluate safety effect individualize sodium concentration dialysate accord patient 's plasma sodium level . We hypothesize patient less thirst less weight gain intervention lead easy fluid removal less episodes hypotension .</brief_summary>
	<brief_title>Safety Dialysate Sodium Individualization Hemodialysis Patients With Intradialytic Hypotension</brief_title>
	<detailed_description>Hypertension intradialytic hypotension common complication patient chronic maintenance hemodialysis ( HD ) . Sodium balance important mediating process . Recent evidence show individualization sodium concentration dialysate match patient 's serum sodium result less thirst , less interdialytic weight gain , less HD-related symptom , good blood pressure control . In project plan evaluate safety tolerability sodium individualization hypotension-prone patient order generate pilot data large study patient intradialytic hypotension . In protocol , recruit 7 hypotension-prone subject . We use open-label cross-over design randomize block . After 3-week baseline period pre-HD serum sodium measure weekly establish patient 's average serum sodium , subject randomized 2 week standard dialysate sodium ( 140 mmol/L ) individualize dialysate sodium ( concentration average pre-HD serum sodium baseline period ) , cross another 2 week ( total study period 7 week , 2 week baseline , 4 week intervention ) . The remainder dialysis prescription , prescribe dry weight vasoactive drug remain unchanged throughout study . Clinical information , pre/intra/post-HD blood pressure hemodynamics ( cardiac output systemic vascular resistance ) , frequency severity intradialytic symptom relate hypotension collect HD session 4 week intervention .</detailed_description>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Dialysis Solutions</mesh_term>
	<criteria>Hemodialysis patient intradialytic hypotension Atrial fibrillation Bilateral upper extremity arteriovenous access Average plasma sodium &gt; 139</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Renal dialysis</keyword>
	<keyword>Hypotension</keyword>
	<keyword>Dialysis solution</keyword>
</DOC>